arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Ernexa Therapeutics Inc.

ERNA

$4.41 ▼ -0.09 (-2.00%) at close

17 Visible periods

31 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, Ernexa Therapeutics Inc. shows weak fundamentals, weighed down by Return on Invested Capital and Interest Coverage. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $27.8M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -386.9% ↗

FCF / Share $-1.12 ↗

Trailing P/E —

Price / Book 14.4x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

17-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$582.00K

↑ +755.9% —

Net Income Profit after all expenses

$-14.08M

↑ +68.4% —

Operating Margin Operating profit as % of sales

-108.8%

↓ -1122.7% —

FCF / Share Free cash flow per share

$-1.12

↑ +5.8% —

Long-Term Debt Long-term obligations

$532.00K

↓ -85.8% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Invested CapitalReturn on Invested Capital of -386.9% is weak on an absolute basis (target > 10%)
Interest CoverageInterest Coverage of -423.59x is weak on an absolute basis (target > 5x)
FCF / Net IncomeFCF / Net Income of 0.50x is weak on an absolute basis (target > 1x)

Health Breakdown

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Revenue Growth YoY (%)	—	755.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+9349%)	—	—	—	-70.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-984%)	-15.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-289%)	9.7% Fair ↑ Fair Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+21%)	-4.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-158%)	-9.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-213%)	-5.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-173%)	9.7% Fair ↑ Fair Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+21%)	-1.3% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-116%)	0.8% Caution Caution Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-90%)	-5.7% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-171%)	—	—
EPS Growth YoY (%)	31.3% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	20.1% Good ↓ Good Declining Year-over-year change in earnings per share Optimal: > 10%	49.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	85.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	68.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-105.6% Weak ↑ Weak Improving Year-over-year change in net income	11.8% Fair ↑ Fair Improving Year-over-year change in net income	79.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-2675.7% Weak ↓ Weak Declining Year-over-year change in net income	-115.7% Weak ↑ Weak Improving Year-over-year change in net income	-690.3% Weak ↓ Weak Declining Year-over-year change in net income	76.0% Excellent ↑ Excellent Improving Year-over-year change in net income	63.2% Excellent ↑ Excellent Improving Year-over-year change in net income	59.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-43.7% Weak ↑ Weak Improving Year-over-year change in net income	-377.7% Weak ↓ Weak Declining Year-over-year change in net income	-5.8% Weak ↑ Weak Improving Year-over-year change in net income	70.9% Excellent Excellent Year-over-year change in net income	-754.8% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	5.8% Fair ↓ Fair Declining Year-over-year change in free cash flow	69.1% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	44.9% Excellent Excellent Year-over-year change in free cash flow	36.2% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	-77.3% Weak Weak Compound annual revenue growth over 3 years	—	—	-35.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-3.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-1.6% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-6.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-2.1% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	0.6% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	3.0% Caution Caution Compound annual revenue growth over 3 years	-2.1% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	—	-50.6% Weak Weak Compound annual revenue growth over 5 years	-68.9% Weak Weak Compound annual revenue growth over 5 years	—	—	-25.0% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-5.3% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-0.4% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-2.4% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-1.3% Weak Weak Compound annual revenue growth over 5 years	-0.6% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	-108.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-825%)	-8.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-159%)	0.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-94%)	-6.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-144%)	-10.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-168%)	-28.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-287%)	-18.2% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-221%)	-4.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-131%)	-4.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-129%)	-13.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-191%)	-1.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-109%)	—
Effective Tax Rate (%) (%)	0.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	19.8% Good Good Actual taxes paid relative to pre-tax income Optimal: 15-25%	-6.5% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	-76.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-734%)	-10.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-186%)	-1.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-109%)	-5.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-142%)	-13.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-209%)	-29.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-346%)	-19.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-261%)	-4.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-137%)	-4.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-134%)	-14.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-219%)	-1.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-113%)	—
FCF Margin (%) (%)	—	—	—	—	—	-67.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	13.2% Fair ↑ Fair Improving Free cash flow as a percentage of revenue Optimal: > 10%	3.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-0.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-1.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-21.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	3.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-4.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	6.0% Caution Caution Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.50x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.36x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.19x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-1.28x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-2.77x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.17x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.14x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	-0.93x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.30x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-3.77x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Return on Invested Capital (%)	-386.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-922.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-946.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-274.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-446.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-455.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-35.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	1.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-27.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-44.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-141.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-40.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-2.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-159.7% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-297.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-43.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-149.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-360.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-168.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	1.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-42.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-28.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-2.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	—	—	—	-203.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1453%)	—	—	-40.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-368%)	-3.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-125%)	-19.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-230%)	-71.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-579%)	-187.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1352%)	-46.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-407%)	-11.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-176%)	-12.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-184%)	-53.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-459%)	-4.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-128%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Debt to Equity (x)	—	—	—	—	—	0.63x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: At sector avg	—	0.54x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-10%)	—	—	—	0.49x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-19%)	0.17x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-71%)	—	—	—	—
Interest Coverage (x)	-423.59x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-90.08x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-120.09x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1107.23x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-505.48x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-53.47x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-7.47x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	0.69x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3.30x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4.41x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-24.36x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-21.26x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-43.04x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-24.14x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-63.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	-3.22x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	—	$-1.73M	$-7.58M	$-11.45M	$-16.98M	$-245.00K	$-3.21M	$1.21M	$-3.38M	$-5.69M	$-3.22M	$-1.87M	$-3.86M	$-2.72M	$-1.37M	$-3.91M	$-3.64M
Debt / EBITDA (x)	—	—	—	—	—	-0.10x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	1.26x Good Good Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	-2.66x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.92x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Revenue per Share (USD)	—	$0.04	$0.01	$0.00	—	—	—	—	—	—	—	—	—	—	—	$16.84	—
Basic EPS, GAAP (USD)	$-2.24	$-3.26	$-4.08	$-8.06	$-56.61	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-1.12	$-1.19	$-3.84	$-6.97	$-10.92	—	—	—	—	—	—	—	—	—	—	$1.00	—
Book Value per Share (USD)	$0.31	$0.03	$0.41	$2.36	$9.81	$11.48	$70.20	$96.24	$87.84	$71.97	$83.24	$4.73	$4.68	—	—	$6.29	—
Tangible Book Value per Share (USD)	$0.05	$-0.01	$0.03	$1.96	$9.02	$11.48	$60.60	$86.96	$71.91	$55.39	$63.58	$4.26	$4.08	—	—	$5.45	—
Basic Weighted Avg Shares (shares)	6.31M	13.65M	5.31M	3.05M	2.17M	—	—	—	—	—	—	—	—	1,726	—	1.50M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Working Capital (USD)	$20.00K	$-586.00K	$3.03M	$6.03M	$15.09M	$-636.00K	$-25.00K	$2.76M	$-1.11M	$4.02M	$3.99M	$7.78M	$4.31M	$841.00K	$-1.07M	$1.89M	—
LT Debt (USD)	—	—	—	—	—	$532.00K	—	$3.75M	—	—	—	$5.32M	$1.59M	—	—	—	—
Total Equity (USD)	$2.40M	$1.70M	$2.23M	$12.11M	$25.50M	$851.00K	$5.09M	$6.92M	$5.54M	$4.07M	$3.85M	$10.92M	$9.20M	$7.89M	$6.35M	$9.46M	$9.42M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗
Sales/Revenue/Turnover (USD)	—	$582.00K	$68.00K	$0.00	—	$5.80M	$19.81M	$23.34M	$21.27M	$22.31M	$24.52M	$26.05M	$23.75M	$24.06M	$23.87M	$25.31M	—
Depreciation Expense (USD)	$65.00K	$139.00K	$84.00K	$161.00K	$117.00K	$1.19M	$2.88M	$2.76M	$2.32M	$2.89M	$3.10M	$2.75M	$2.85M	$2.88M	$3.26M	$3.20M	—
Net Income, GAAP (USD)	$-14.08M	$-44.54M	$-21.67M	$-24.58M	$-122.55M	$-4.42M	$-2.05M	$-259.00K	$-1.08M	$-2.92M	$-7.23M	$-5.03M	$-1.05M	$-995.00K	$-3.42M	$-400.00K	—
Operating Cash Flow (USD)	$-7.02M	$-15.84M	$-20.41M	$-20.98M	$-23.49M	$-3.89M	$2.74M	$1.36M	$549.00K	$23.00K	$-4.18M	—	—	$2.16M	$574.00K	$2.83M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 66 quarters

Ernexa Therapeutics Inc.

Analytical Summary

17-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare ERNA with peers